Macular disease treatment PBS listed

close up of green eye
Macular Disease Foundation Australia today applauded the Federal Government’s decision to place the registered drug ranibizumab (Lucentis) on the PBS, enabling patients affordable access to this sight saving treatment for Diabetic Macular Edema and Retinal Vein Occlusion. The Foundation has been advocating strongly for access and affordability for registered treatment for these serious macular diseases,

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Forgot Password?Why do I need to login & stay in?

Previous Ads to educate on ice
Next Bid to end rheumatic heart disease